BG Stock Analysis: Bunge Global | NYSE
Farm Products | NYSE, USA | Market Cap: 22.628m USD | 12M Return: 66.9% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 169M
EPS Trend: -95.7%
Qual. Beats: 1
Rev. Trend: 27.9%
Qual. Beats: -1
Warnings
Tailwinds
Seasonality 10.5 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Bunge Global SA is a global agribusiness and food company headquartered in Chesterfield, Missouri, with operations spanning four segments: Soybean Processing and Refining, Softseed Processing and Refining, Other Oilseeds Processing and Refining, and Grain Merchandising and Milling. The company purchases, stores, transports, processes, distributes, refines, markets, and sells agricultural commodities and related products, including soybeans, softseeds, corn, wheat, barley, cotton, pulses, and sugar, serving the food, animal feed, and biofuel industries.
Founded in 1818, Bunge is one of the worlds largest oilseed processors and a member of the ABCD group of major global agricultural commodity traders (alongside ADM, Cargill, and Louis Dreyfus). The company also produces biodiesel and fertilizer, and operates milling operations for wheat and sugar, reflecting the vertically integrated nature typical of large-scale agricultural processors. Bunge is listed on the NYSE under the ticker BG and falls within the Consumer Staples sector, specifically the Agricultural Products & Services sub-industry.
- Soybean crush margins drive core oilseed segment earnings
- Viterra acquisition expands global grain origination scale
- Biodiesel demand lifts edible oil processing margins
| Net Income: 686.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.00 > 0.02 and ΔFCF/TA 3.14 > 1.0 |
| NWC/Revenue: 12.61% < 20% (prev 17.22%; Δ -4.61% < -1%) |
| CFO/TA 0.01 > 3% & CFO 578.0m > Net Income 686.0m |
| Net Debt (16.2b) to EBITDA (2.37b): 6.84 < 3 |
| Current Ratio: 1.60 > 1.5 & < 3 |
| Outstanding Shares: last quarter (195.7m) vs 12m ago 44.55% < -2% |
| Gross Margin: 4.14% > 18% (prev 6.09%; Δ -1.95% > 0.5%) |
| Asset Turnover: 217.0% > 50% (prev 192.6%; Δ 24.44% > 0%) |
| Interest Coverage Ratio: 2.42 > 6 (EBIT TTM 1.55b / Interest Expense TTM 641.0m) |
| A: 0.21 (Total Current Assets 27.1b - Total Current Liabilities 16.9b) / Total Assets 47.6b |
| B: 0.28 (Retained Earnings 13.2b / Total Assets 47.6b) |
| C: 0.04 (EBIT TTM 1.55b / Avg Total Assets 37.1b) |
| D: 0.53 (Book Value of Equity 16.0b / Total Liabilities 30.1b) |
| Altman-Z'' = 3.15 = A |
| DSRI: 1.08 (Receivables 4.85b/2.86b, Revenue 80.5b/51.3b) |
| GMI: 1.47 (GM 6.09% / 4.14%) |
| AQI: 1.39 (AQ_t 0.14 / AQ_t-1 0.10) |
| SGI: 1.57 (Revenue 80.5b / 51.3b) |
| TATA: 0.00 (NI 686.0m - CFO 578.0m) / TA 47.6b) |
| Beneish M = -1.90 (Cap -4..+1) = B |
As of July 21, 2026, the stock is trading at USD 120.49 with a total of 1,254,464 shares traded. Over the past week, the price has changed by +2.63%, over one month by +8.14%, over three months by -1.02% and over the past year by +66.87%.
Current recommended Stop Loss: 115.90 (which is 3.8% or 1.3 ATR below the current price).
Bunge Global has received a consensus analysts rating of 3.90. Therefore, it is recommended to buy BG.
- StrongBuy: 4
- Buy: 1
- Hold: 5
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 141.4 | 17.4% |
P/E Trailing = 30.8545
P/E Forward = 14.5349
P/S = 0.2809
P/B = 1.4196
P/EG = 1.7053
Revenue TTM = 80.5b USD
EBIT TTM = 1.55b USD
EBITDA TTM = 2.37b USD
Long Term Debt = 9.95b USD (from longTermDebt, last quarter)
Short Term Debt = 5.21b USD (from shortTermDebt, last quarter)
Debt = 17.9b USD (from shortLongTermDebtTotal, last quarter) + Leases 1.64b
Net Debt = 16.2b USD (calculated: Debt 17.9b - CCE 1.70b)
Enterprise Value = 38.9b USD (22.6b + Debt 17.9b - CCE 1.70b)
Interest Coverage Ratio = 2.42 (Ebit TTM 1.55b / Interest Expense TTM 641.0m)
EV/FCF = 1000.0x (Enterprise Value 38.9b / FCF TTM 14.0m)
FCF Yield = 0.04% (FCF TTM 14.0m / Enterprise Value 38.9b)
FCF Margin = 0.02% (FCF TTM 14.0m / Revenue TTM 80.5b)
Net Margin = 0.85% (Net Income TTM 686.0m / Revenue TTM 80.5b)
Gross Margin = 4.14% ((Revenue TTM 80.5b - Cost of Revenue TTM 77.2b) / Revenue TTM)
Gross Margin QoQ = 3.50% (prev 5.36%)
Tobins Q-Ratio = 0.82 (Enterprise Value 38.9b / Total Assets 47.6b)
Interest Expense / Debt = 3.58% (Interest Expense 641.0m / Debt 17.9b)
Taxrate = 21.30% (194.0m / 911.0m)
NOPAT = 1.22b (EBIT 1.55b * (1 - 21.30%))
Current Ratio = 1.60 (Total Current Assets 27.1b / Total Current Liabilities 16.9b)
Debt / Equity = 1.12 (Debt 17.9b / totalStockholderEquity, last quarter 16.0b)
Debt / EBITDA = 6.84 (Net Debt 16.2b / EBITDA 2.37b)
Debt / FCF = 1.16k (out of range, set to none) (Net Debt 16.2b / FCF TTM 14.0m)
Total Stockholder Equity = 14.7b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.85% (Net Income 686.0m / Total Assets 47.6b)
RoE = 4.68% (Net Income TTM 686.0m / Total Stockholder Equity 14.7b)
RoCE = 6.31% (EBIT 1.55b / Capital Employed (Equity 14.7b + L.T.Debt 9.95b))
RoIC = 3.58% (NOPAT 1.22b / Invested Capital 34.1b)
WACC = 4.73% (E(22.6b)/V(40.6b) * Re(6.24%) + D(17.9b)/V(40.6b) * Rd(3.58%) * (1-Tc(0.21)))
Discount Rate = 6.24% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 70.87 | Cagr: 13.57%
[DCF] Terminal Value 75.44% ; FCFF base≈14.0m ; Y1≈14.1m ; Y5≈14.9m
[DCF] Fair Price = N/A (negative equity: EV 231.6m - Net Debt 16.2b = -16.0b; debt exceeds intrinsic value)
EPS Correlation: -95.74 | EPS CAGR: -24.74% | SUE: 4.0 | # QB: 1
Revenue Correlation: 27.94 | Revenue CAGR: 4.24% | SUE: -1.48 | # QB: -1
EPS current Quarter (2026-06-30): EPS=1.93 | Chg30d=+0.18% | Revisions=-25% | Analysts=7
EPS next Quarter (2026-09-30): EPS=2.59 | Chg30d=+2.22% | Revisions=+25% | Analysts=7
EPS current Year (2026-12-31): EPS=9.45 | Chg30d=+0.20% | Revisions=+25% | GrowthEPS=+24.8% | GrowthRev=+28.5%
EPS next Year (2027-12-31): EPS=11.15 | Chg30d=+2.45% | Revisions=+40% | GrowthEPS=+18.0% | GrowthRev=+3.9%
[Analyst] Revisions Ratio: +38% (up=4, down=1)